BoNT-D Light Chain Antibody [DyLight 650]
Novus Biologicals, part of Bio-Techne | Catalog # AF6037W

Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Concentration
Product Specifications
Immunogen
Thr2-Ser428
Accession # P19321
Reactivity Notes
Specificity
Clonality
Host
Isotype
Applications for BoNT-D Light Chain Antibody [DyLight 650]
Western Blot
Formulation, Preparation, and Storage
Purification
Formulation
Preservative
Concentration
Shipping
Stability & Storage
Background: BoNT-D Light Chain
There are seven serotypes of Botulinum Neurotoxins (BoNTs) produced by various strains of Clostridium botulinum. BoNTs are synthesized as inactive single chain protein precursors and activated by proteolytic cleavage to generate disulfide-linked two-chain proteins. The 50 kDa light chain contains the catalytic domain, whereas the 100 kDa heavy chain contains an internal translocation domain and a receptor binding domain. BoNTs are the most potent protein toxins for humans. As zinc proteases, they cleave SNARE proteins to elicit flaccid paralysis in botulism by blocking acetylcholine release at the neuromuscular junction.
E. coli-expressed recombinant BoNT light chains are active proteases. However, they are not toxic because they cannot enter into host cells in the absence of the heavy chains.
Long Name
Alternate Names
Additional BoNT-D Light Chain Products
Product Documents for BoNT-D Light Chain Antibody [DyLight 650]
Product Specific Notices for BoNT-D Light Chain Antibody [DyLight 650]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.